Static magnetic fields for treatment of fibromyalgia: A randomized controlled trial

被引:86
作者
Alfano, AP
Taylor, AG
Foresman, PA
Dunkl, PR
McConnell, GG
Conaway, MR
Gillies, GT
机构
[1] Univ Virginia Hlth Syst, Dept Phys Med & Rehabil, Charlottesville, VA 22903 USA
[2] Univ Virginia, Ctr Study Complementary & Alternat Therapies, Charlottesville, VA USA
[3] Univ Virginia, Dept Hlth Evaluat Sci, Charlottesville, VA USA
[4] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA
关键词
D O I
10.1089/107555301300004538
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: To test effectiveness of static magnetic fields of two different configurations, produced by magnetic sleep pads, as adjunctive therapies in decreasing patient pain perception and improving functional status in individuals with fibromyalgia. Design: Randomized, placebo-controlled, 6-month trial conducted from November 1997 through December 1998. Setting and subjects: Adults who met the 1990 American College of Rheumatology criteria for fibromyalgia were recruited through clinical referral and media announcements and evaluated at a university-based clinic. Interventions: Subjects in Functional Pad A group used a pad for 6 months that provided whole-body exposure to a low, uniform static magnetic field of negative polarity. Subjects in the Functional Pad B group used a pad for 6 months that exposed them to a low static magnetic field that varied spatially and in polarity. Subjects in two Sham groups used pads that were identical in appearance and texture to the functional pads but contained inactive magnets; these groups were combined for analysis. Subjects in the Usual Care group continued with their established treatment regimens. Outcome measures: Primary outcomes were the change scores at 6 months in the following measures: functional status (Fibromyalgia Impact Questionnaire), pain intensity ratings, tender point count, and a tender point pain intensity score. Results: There was a significant difference among groups in pain intensity ratings (p = 0.03), with Functional Pad A group showing the greatest reduction from baseline at 6 months. All four groups showed a decline in number of tender points, but differences among the groups were not significant (p = 0.72). The functional pad groups showed the largest decline in total tender point pain intensity, but overall differences were not significant (p = 0.25). Improvement in functional status was greatest in the functional pad groups, but differences among groups were not significant (p = 0.23). Conclusions: Although the functional pad groups showed improvements in functional, status, pain intensity level, tender point count, and tender point intensity after 6 months of treatment, with the exception of pain intensity level these improvements did not differ significantly from changes in the Sham group or in the Usual Care group.
引用
收藏
页码:53 / 64
页数:12
相关论文
共 39 条
[1]  
AGRESTI A, 1990, CATEGORICAL DATA ANA, P322
[2]   Advances in the treatment of fibromyalgia:: Current status and future directions [J].
Alarcón, GS ;
Bradley, LA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 315 (06) :397-404
[3]   EFFECTS OF A STATIC MAGNETIC-FIELD ON HEMOGLOBIN STRUCTURE AND FUNCTION [J].
ATEF, MM ;
ELBASET, MSA ;
ELKAREEM, A ;
AIDA, S ;
FADEL, MA .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1995, 17 (02) :105-111
[4]  
Blackman CF, 1998, BIOELECTROMAGNETICS, V19, P204, DOI 10.1002/(SICI)1521-186X(1998)19:4<204::AID-BEM2>3.0.CO
[5]  
2-5
[6]   Effect of AC and DC magnetic field orientation on nerve cells [J].
Blackman, CF ;
Blanchard, JP ;
Benane, SG ;
House, DE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) :807-811
[7]  
BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728
[8]   MEASUREMENT AND ANALYSIS OF STATIC MAGNETIC-FIELDS THAT BLOCK ACTION-POTENTIALS IN CULTURED NEURONS [J].
CAVOPOL, AV ;
WAMIL, AW ;
HOLCOMB, RR ;
MCLEAN, MJ .
BIOELECTROMAGNETICS, 1995, 16 (03) :197-206
[9]   Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms [J].
Clauw, DJ ;
Chrousos, GP .
NEUROIMMUNOMODULATION, 1997, 4 (03) :134-153
[10]   Neuroendocrine abnormalities in fibromyalgia and related disorders [J].
Crofford, LJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 315 (06) :359-366